Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

Regular Fanconi anemia cells aren't sensitive to resveratrol

Regular Fanconi anemia cells aren't sensitive to resveratrol

FDA approves Bosulif to treat chronic myelogenous leukemia

FDA approves Bosulif to treat chronic myelogenous leukemia

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Evidence lacking for use of misoprostol in PPH prevention

Evidence lacking for use of misoprostol in PPH prevention

Cyclin D3 protein regulates size and quantity of RBCs

Cyclin D3 protein regulates size and quantity of RBCs

Novartis receives EC approval for Jakavi to treat myelofibrosis

Novartis receives EC approval for Jakavi to treat myelofibrosis

New results describe development of DC cancer vaccine with enhanced immunogenic potential

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Study finds 'inconclusive' evidence to support use of WHO-backed drug to prevent hemorrhage during labor

Study finds 'inconclusive' evidence to support use of WHO-backed drug to prevent hemorrhage during labor

Researchers identify molecular and protein signatures that predict HCV virus-induced liver injury

Researchers identify molecular and protein signatures that predict HCV virus-induced liver injury

Study tracks effects of heavy PAE on growth and body composition throughout childhood

Study tracks effects of heavy PAE on growth and body composition throughout childhood

Researchers discover why people with sickle cell disease get milder cases of malaria

Researchers discover why people with sickle cell disease get milder cases of malaria

HAS-BLED proves predictive ability

HAS-BLED proves predictive ability

‘Low’ toxicity for phase I cancer trials

‘Low’ toxicity for phase I cancer trials

Endocrine Society revises clinical practice guideline for management of thyroid dysfunction

Endocrine Society revises clinical practice guideline for management of thyroid dysfunction

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Medicare payments for anemia drug too high; Feds seek fix to glitch that denies some hospitalized beneficiaries coverage for follow-up nursing home care

Medicare payments for anemia drug too high; Feds seek fix to glitch that denies some hospitalized beneficiaries coverage for follow-up nursing home care

First Edition: August 10, 2012

First Edition: August 10, 2012

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.